S. Boulardii | Alixir Life

S. Boulardii

Digestive Support

  • Protects the gut and helps alleviates Irritable Bowel Syndrome and Diarrhea
  • Helps cardiovascular health

OVERVIEW

Protects the gut and helps to alleviate Irritable Bowel Syndrome and diarrhea.

Probiotics are living organisms that are essential for intestinal health. Many intestinal problems are caused by bacteria imbalances in our gut. Probiotics promote healthy digestion and contribute to our immune health by balancing “bad” bacteria throughout our digestive tracts.

Our Probiotic Blend contains the yeasts Saccharomyces Boulardii and MannanOligoSaccharides (MOS). Saccharomyces Boulardii survives the acid in our stomachs, thereby arriving in the large intestine where it helps to balance the overall colony of microbes. MOS is an oligosaccharide (a carbohydrate) that prevents opportunistic bacteria from multiplying.

Product Type: 1 Veggie Capsule
Dosage:  5 Billion Viable Cell (Minimum)†

Ingredients

Saccharomyces boulardii (a S, cerevisiae Strain), Bio-MOS, [Derived from S. cerevisiae, Source of MOS (MannanOligoSaccharides)], Silicon dioxide and vitamin C. Capsule consists of hydroxypropylmethylcellulose.

does not contain

milk, eggs, fish, shellfish, tree nuts, peanuts, wheat or soybeans

summary of research

  • Protects the gut and alleviates Irritable Bowel Syndrome and Diarrhea

    Having fungus like Candida albicans in your body is natural. However, if its numbers become too large, it can cause gastrointestinal (esophagus, stomach, intestine and rectum) infections. Studies show Saccharomyces Boulardii can counterbalance and subdue this harmful fungus,[1] antibiotic-associated diarrhea (AAD),[2] and infectious and functional diarrhea.[3] In a 1995 double-blind, placebo-controlled study, 193 people were divided into a group that took Saccharomyces Boulardii and a placebo. Of the 97 patients taking the Probiotic, 7 (7.2%) reported diarrhea, whereas 14 of 96 (14.6%) people taking the placebo suffered from diarrhea.[4] One study compared yoghurt with Saccharomyces Boulardii in counteracting diarrhea and found the duration of diarrhea was shorter with the Probiotic than with yoghurt.[5]

     

    More serious gastrointestinal problems that can be alleviated by or prevented by a Probiotic Blend of Saccharomyces Boulardii are Irritable Bowel Syndrome,[6] colon cancer [7] [8] and intestinal barrier function altering diseases.[9] Irritable Bowel Syndrome is caused by changes in the microbes in your intestine. A 2015 meta-analysis of a total of 1793 patients confirms the Probiotic is effective in reducing pain and severity of symptoms like distension (enlargement of the abdomen), bloating, and flatulence (passing gas).[10] One of the ways to prevent colon cancer is to maintain a healthy gut. One large scale study shows Probiotics, via yoghurt, helped significantly decrease colon cancer risk in 45,241 subjects. [11]

     

    Research Score: Very Strong

  • May improve cardiovascular health

    A 2016 study reviewed the effects of Probiotics on the heart. It concluded that Probiotic supplementation significantly decreases cardiovascular disease biomarkers such as LDL (bad) cholesterol, total cholesterol, and inflammatory biomarkers. [12] [13]

     

    Research Score: Promising

  • References

    1. The antagonistic effect of Saccharomyces boulardii on Candida albicans filamentation, adhesion and biofilm formation., Krasowska A, Murzyn A, Dyjankiewicz A, Łukaszewicz M, Dziadkowiec D., FEMS yeast research, 2009

    2. Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo.

    McFarland LV, Surawicz CM, Greenberg RN, Elmer GW, Moyer KA, Melcher SA, Bowen KE, Cox JL., The American Journal of Gastoenterology, 1995, Am J Trop Med Hyg. 2010 Mar; 82(3): 488–491.

    doi: 10.4269/ajtmh.2010.09-0529

    3. Beneficial effects of Saccharomyces boulardii CNCM I-745 on clinical disorders associated with intestinal barrier disruption., Terciolo C1,2, Dapoigny M3, Andre F4., Clin Exp Gastroenterol. 2019 Feb 11;12:67-82. doi: 10.2147/CEG.S181590. eCollection 2019.

    4. Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo.

    McFarland LV, Surawicz CM, Greenberg RN, Elmer GW, Moyer KA, Melcher SA, Bowen KE, Cox JL., The American Journal of Gastoenterology, 1995, Am J Trop Med Hyg. 2010 Mar; 82(3): 488–491.

    doi: 10.4269/ajtmh.2010.09-0529

    5. Clinical Efficacy Comparison of Saccharomyces boulardii and Yogurt Fluid in Acute Non-Bloody Diarrhea in Children: A Randomized, Controlled, Open Label Study, Makbule Eren,* Ener C. Dinleyici, and Yvan Vandenplas,

    6. Didari T, Mozaffari S, Nikfar S, Abdollahi M. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis. World Journal of Gastroenterology?: WJG. 2015;21(10):3072-3084. doi:10.3748/wjg.v21.i10.3072.

    7. Pala V, Sieri S, Berrino F, et al. Yogurt consumption and risk of colorectal cancer in the Italian European prospective investigation into cancer and nutrition cohort. Int J Cancer. 2011;129(11):2712-9.

    8. Clinical Efficacy Comparison of Saccharomyces boulardii and Yogurt Fluid in Acute Non-Bloody Diarrhea in Children: A Randomized, Controlled, Open Label Study, Makbule Eren, Ener C. Dinleyici, and Yvan Vandenplas,

    9. Beneficial effects of Saccharomyces boulardii CNCM I-745 on clinical disorders associated with intestinal barrier disruption., Terciolo C1,2, Dapoigny M3, Andre F4., Clin Exp Gastroenterol. 2019 Feb 11;12:67-82. doi: 10.2147/CEG.S181590. eCollection 2019.

    10. Didari T, Mozaffari S, Nikfar S, Abdollahi M. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis. World Journal of Gastroenterology?: WJG. 2015;21(10):3072-3084. doi:10.3748/wjg.v21.i10.3072.

    11. Pala V, Sieri S, Berrino F, et al. Yogurt consumption and risk of colorectal cancer in the Italian European prospective investigation into cancer and nutrition cohort. Int J Cancer. 2011;129(11):2712-9.

    12. Thushara RM, Gangadaran S, Solati Z, Moghadasian MH. Cardiovascular benefits of probiotics: a review of experimental and clinical studies. Food Funct. 2016;7(2):632-42.

    13. Intersections between Microbiome and Heart Failure: Revisiting the Gut Hypothesis, Yuji Nagatomo, MD, PhD and W. H. Wilson Tang, MD, J Card Fail. 2015 Dec; 21(12): 973–980., Published online 2015 Oct 3. doi: 10.1016/j.cardfail.2015.09.017